ARCHIVES

Fondaparinux Prevents DVT In Acutely III Medical Patients

This article is from The Cancer Letter archive.

Vol. 27 No. 1 | January 30, 2004

Download PDF Visit The Full Archive

Related Articles

NHLBI Advisers Commit Funding TO NCI’s Women’s Health Trials, Tamoxifen Trial

March 8, 1991

High Response Rate of Hairy Cell Leukemia Patients to Immunotoxin Treatment In Phase I

April 27, 2001

Sharp To Direct New Institute For Brain Research At MIT.

March 3, 2000

GM Foundation Awards Prizes

June 13, 2003

Rosenberg Begins Trial To Immunize Patient against Tumor

October 11, 1991

NCI-Approved Clinical Trials

January 26, 2007